Yahoo Finance

Regeneron to acquire bankrupt genetic tester 23andMe

Regeneron Pharmaceutical (REGN) is buying 23andMe’s (MEHCQ) genetics business out of bankruptcy for $256 million, aiming to boost its drug discovery capabilities using DNA data. Yahoo Finance Senior Reporter Anjalee Khemlani explains how the deal ties into Regeneron’s broader strategy and addresses privacy concerns. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.